UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons

AIDS (London), 2016-07, Vol.30 (11), p.1731-1743

2016

Volltextzugriff (PDF)

Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland

Emerging infectious diseases, 2011-06, Vol.17 (6), p.1074-1078

2011

Volltextzugriff (PDF)

Antiretroviral Drug-Related Liver Mortality Among HIV-Positive Persons in the Absence of Hepatitis B or C Virus Coinfection: The Data Collection on Adverse Events of Anti-HIV Drugs Study

Clinical infectious diseases, 2013-03, Vol.56 (6), p.870-879

2013

Volltextzugriff (PDF)

Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared

International journal of infectious diseases, 2016-10, Vol.51 (C), p.97-102

2016

Volltextzugriff (PDF)

Cohort Profile: The Zurich Primary HIV Infection Study

Microorganisms (Basel), 2024-01, Vol.12 (2), p.302

2024

Volltextzugriff (PDF)

Subclinical Atherosclerosis Imaging in People Living with HIV

Journal of clinical medicine, 2019-07, Vol.8 (8), p.1125

2019

Volltextzugriff (PDF)

Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study

EClinicalMedicine, 2019-08, Vol.13, p.91-100

2019

Volltextzugriff (PDF)

Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study

PloS one, 2015-07, Vol.10 (7), p.e0133879

2015

Volltextzugriff (PDF)

Hyperkalzämie als Folge von?

Primary and hospital care (Deutsche Ausg. Internet), 2023-10

2023

Volltextzugriff (PDF)

Meningoencephalitis with Subdural Empyema Caused by Toxigenic Clostridium perfringens Type A

Journal of Clinical Microbiology, 2012-10, Vol.50 (10), p.3409-3411

2012

Volltextzugriff (PDF)

CME. Larva migrans

Praxis (Bern. 1994), 2014-12, Vol.103 (25), p.1491

2014

Volltextzugriff (PDF)

Mpox in people with advanced HIV infection: a global case series

The Lancet (British edition), 2023-03, Vol.401 (10380), p.939-949

2023

Volltextzugriff (PDF)

Influence of antiretroviral therapy on liver disease

Current opinion in HIV & AIDS, 2011-07, Vol.6 (4), p.272

2011

Volltextzugriff (PDF)

Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART

Nature communications, 2019-07, Vol.10 (1), p.3193-11, Article 3193

2019

Volltextzugriff (PDF)

Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative persons

European heart journal, 2018-06, Vol.39 (23), p.2147-2154

2018

Volltextzugriff (PDF)

Determinants of HIV-1 broadly neutralizing antibody induction

Nature medicine, 2016-11, Vol.22 (11), p.1260-1267

2016

Volltextzugriff (PDF)

Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study

Clinical infectious diseases, 2017-02, Vol.64 (4), p.490-497

2017

Volltextzugriff (PDF)

High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between 2001 and 2013

Journal of hepatology, 2015-09, Vol.63 (3), p.573-580

2015

Volltextzugriff (PDF)

Risk Factors for Anal Cancer in Persons Infected With HIV: A Nested Case-Control Study in the Swiss HIV Cohort Study

American journal of epidemiology, 2013-09, Vol.178 (6), p.877-884

2013

Volltextzugriff (PDF)

Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation

European journal of clinical pharmacology, 2016-07, Vol.72 (7), p.859-867

2016

Volltextzugriff (PDF)

The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile

HIV medicine, 2020-01, Vol.21 (1), p.30-42

2020

Volltextzugriff (PDF)

Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort Study

Clinical infectious diseases, 2023-01, Vol.76 (1), p.48-56

2023

Volltextzugriff (PDF)

Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV): A Study Combining Modelling and Swiss HIV Cohort Data

Clinical infectious diseases, 2024-01, Vol.78 (1), p.98-110

2024

Volltextzugriff (PDF)

Tracing HIV-1 strains that imprint broadly neutralizing antibody responses

Nature (London), 2018-09, Vol.561 (7723), p.406-410

2018

Volltextzugriff (PDF)

Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland

Emerging infectious diseases, 2011-06, Vol.17 (6), p.1074-1078

2011

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(76)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons

Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland

Antiretroviral Drug-Related Liver Mortality Among HIV-Positive Persons in the Absence of Hepatitis B or C Virus Coinfection: The Data Collection on Adverse Events of Anti-HIV Drugs Study

Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared

Cohort Profile: The Zurich Primary HIV Infection Study

Subclinical Atherosclerosis Imaging in People Living with HIV

Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study

Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study

Hyperkalzämie als Folge von?

Meningoencephalitis with Subdural Empyema Caused by Toxigenic Clostridium perfringens Type A

CME. Larva migrans

Mpox in people with advanced HIV infection: a global case series

Influence of antiretroviral therapy on liver disease

Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART

Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative persons

Determinants of HIV-1 broadly neutralizing antibody induction

Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study

High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between 2001 and 2013

Risk Factors for Anal Cancer in Persons Infected With HIV: A Nested Case-Control Study in the Swiss HIV Cohort Study

Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation

The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile

Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort Study

Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV): A Study Combining Modelling and Swiss HIV Cohort Data

Tracing HIV-1 strains that imprint broadly neutralizing antibody responses

Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland

Suchergebnisse filtern